Ishag Adam, Amel A Hagelnur. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAnti-Infective Agents/administration & dosageAnti-Infective Agents/therapeutic useAntiprotozoal Agents/administration & dosageAntiprotozoal Agents/therapeutic useArtemisinins/administration & dosageArtemisinins/therapeutic useArtesunateChildDouble-Blind MethodDrug Therapy, CombinationHumansLeishmaniasis, Cutaneous/drug therapyLeishmaniasis, Cutaneous/parasitologyMiddle AgedPyrimethamine/administration & dosagePyrimethamine/therapeutic useSulfalene/administration & dosageSulfalene/therapeutic useTreatment Outcome
Substances: See more » Anti-Infective AgentsAntiprotozoal AgentsArtemisininsArtesunateSulfalenePyrimethamine
Year: 2009 PMID: 19409761 DOI: 10.1016/j.ijantimicag.2009.03.013
Source DB: PubMed Journal: Int J Antimicrob Agents ISSN: 0924-8579 Impact factor: 5.283